HALO logo
halo search icon
OnKure Therapeutics, Inc. Class A
OnKure Therapeutics, Inc. Class A
OKUR · NAS

OnKure Therapeutics, Inc. Class A

US$3.56

Price Arrow0.26 (7.88%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHALO Earnings MomentumHALO Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

OnKure Therapeutics, Inc. Class A Overview

OKUR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About OKUR

icon

Website

OnKure Therapeutics, Inc. Class A

icon

Telephone

1.702.307.2892

icon

Address

Suite 400, 6707 Winchester Circle, Boulder, CO 80301

Description

OnKure Therapeutics, Inc. engages in discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure and computational chemistry driven drug design platform, committed to improving clinical outcomes for patients by building a robust pipeline of small molecule drugs designed to selectively target specific mutations thought to be key drivers of cancer. It is headquartered in Boulder, CO.

OKUR Price Chart

Key Stats

Market Cap

US$133.31M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 1.91 - 5.38

Trade Value (12mth)

US$130,152.00

1 week

4.43%

1 month

-32.38%

YTD

11.49%

1 year

46.67%

All time high

171.80

Key Fundamentals

EPS 3 yr Growth

-79.20%

EBITDA Margin

0.00%

Operating Cashflow

-$52m

Free Cash Flow Return

-64.60%

ROIC

-74.10%

Interest Coverage

0.00

Quick Ratio

10.30

Other Data

Shares Outstanding (Fully Diluted)

14m

HALO Sector

Healthcare

Next Company Report Date

17-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

OKUR Announcements

Latest Announcements

DateAnnouncements
06 May 26
06 May 26
06 May 26
06 May 26
30 March 26

OKUR Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1,125.46-3.95-4.4locklocklock
EPS (Fully Diluted)
$locklocklocklock-1,125.46-3.95-4.4locklocklock
Growth
%locklocklocklock-5,206.599.6-11.6locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of OnKure Therapeutics, Inc. Class A (OKUR:NAS)?
Halo FAQ
The current share price of OnKure Therapeutics, Inc. Class A (OKUR:NAS) is USD$3.56.
What is the 52-week high share price for OnKure Therapeutics, Inc. Class A (OKUR:NAS)?
Halo FAQ
The 52-week high share price for OnKure Therapeutics, Inc. Class A (OKUR:NAS) is USD$5.38.
What is the 52-week low share price for OnKure Therapeutics, Inc. Class A (OKUR:NAS)?
Halo FAQ
The 52-week low share price for OnKure Therapeutics, Inc. Class A (OKUR:NAS) is USD$1.91.
What is the dividend yield for OnKure Therapeutics, Inc. Class A (OKUR:NAS)?
Halo FAQ
OnKure Therapeutics, Inc. Class A (OKUR:NAS) does not pay a dividend.
What was OnKure Therapeutics, Inc. Class A (OKUR:NAS) last dividend payment?
Halo FAQ
OnKure Therapeutics, Inc. Class A (OKUR:NAS) does not pay a dividend.
What is the franking level for OnKure Therapeutics, Inc. Class A (OKUR:NAS)?
Halo FAQ
OnKure Therapeutics, Inc. Class A (OKUR:NAS) has a franking level of 0.00%.
In which sector is OnKure Therapeutics, Inc. Class A (OKUR:NAS) classified?
Halo FAQ
OnKure Therapeutics, Inc. Class A (OKUR:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.